BNP Paribas Financial Markets Portfolio holdings
BNP Paribas Financial Markets, a core component of BNP Paribas’s Corporate & Institutional Banking (CIB) division, is a global leader in trading and market-making, headquartered in Paris with major hubs in London, New York, Hong Kong, and Singapore. Specializing in derivatives across all asset classes—equities, fixed income, commodities, and foreign exchange—it provides innovative investment, hedging, and financing solutions to corporate clients, institutional investors, and financial institutions worldwide. Known for its advanced technological infrastructure and quantitative expertise, the division excels in structured financing and electronic trading, supported by a robust balance sheet and a diversified business model that proved resilient during the 2008 financial crisis. With a presence in over 50 countries and a client base exceeding 13,000, BNP Paribas Financial Markets drives market liquidity and offers cutting-edge research and execution services, reinforcing its position as a top-tier player in global capital markets.
Top Buys
| 1 |
Visa
V
|
+$333M |
| 2 |
Invesco QQQ Trust
QQQ
|
+$265M |
| 3 |
Motorola Solutions
MSI
|
+$222M |
| 4 |
iShares Russell 2000 ETF
IWM
|
+$220M |
| 5 |
SPDR S&P Biotech ETF
XBI
|
+$193M |
Top Sells
| 1 |
Apple
AAPL
|
+$251M |
| 2 |
SPDR S&P 500 ETF Trust
SPY
|
+$196M |
| 3 |
Alibaba
BABA
|
+$193M |
| 4 |
iShares MSCI Emerging Markets ETF
EEM
|
+$130M |
| 5 |
APC
Anadarko Petroleum
APC
|
+$122M |
Sector Composition
| 1 | Technology | 14.35% |
| 2 | Financials | 12.02% |
| 3 | Consumer Discretionary | 9.44% |
| 4 | Healthcare | 8.58% |
| 5 | Industrials | 6.96% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
2151
Theravance Biopharma
TBPH
$719M
| $153K | ﹤0.01% |
7,879
+2,088
| +36% | +$40.7K |
|
|
NXGN
2152
DELISTED
NextGen Healthcare, Inc. Common Stock
NXGN
| $153K | ﹤0.01% |
9,783
+773
| +9% | +$12.1K |
|
|
FARO
2153
DELISTED
Faro Technologies
FARO
| $152K | ﹤0.01% |
3,150
+389
| +14% | +$18.8K |
|
2154
AnaptysBio
ANAB
$486M
| $151K | ﹤0.01% |
4,317
+1,483
| +52% | +$51.9K |
|
2155
Primoris Services
PRIM
$6.59B
| $151K | ﹤0.01% |
7,693
+643
| +9% | +$12.6K |
|
2156
Enterprise Financial Services Corp
EFSC
$2.18B
| $151K | ﹤0.01% |
3,701
+1,166
| +46% | +$47.5K |
|
|
UNT
2157
DELISTED
UNIT Corporation
UNT
| $150K | ﹤0.01% |
44,373
+6,994
| +19% | +$23.6K |
|
2158
Universal Insurance Holdings
UVE
$697M
| $150K | ﹤0.01% |
4,996
+1,468
| +42% | +$44K |
|
2159
ProShares Ultra Consumer Discretionary
UCC
$16.6M
| $149K | ﹤0.01% |
5,532
+1,872
| +51% | +$50.5K |
|
2160
TriCo Bancshares
TCBK
$1.46B
| $149K | ﹤0.01% |
4,106
-234
| -5% | -$8.49K |
|
2161
Oil States International
OIS
$343M
| $149K | ﹤0.01% |
11,167
-686
| -6% | -$9.12K |
|
|
DBD
2162
DELISTED
Diebold Nixdorf Incorporated
DBD
| $148K | ﹤0.01% |
13,251
-5,443
| -29% | -$61K |
|
2163
Esperion Therapeutics
ESPR
$554M
| $148K | ﹤0.01% |
4,043
+1,182
| +41% | +$43.3K |
|
2164
Brown-Forman Class A
BF.A
$13.2B
| $148K | ﹤0.01% |
2,474
+474
| +24% | +$28.3K |
|
2165
Novartis
NVS
$239B
| $148K | ﹤0.01% |
1,699
+133
| +8% | +$11.6K |
|
|
IPHS
2166
DELISTED
Innophos Holdings, Inc.
IPHS
| $148K | ﹤0.01% |
4,545
-1,003
| -18% | -$32.6K |
|
|
CKH
2167
DELISTED
Seacor Holdings Inc.
CKH
| $147K | ﹤0.01% |
3,122
-382
| -11% | -$18K |
|
2168
BJ's Restaurants
BJRI
$680M
| $147K | ﹤0.01% |
3,783
-467
| -11% | -$18.1K |
|
2169
PJT Partners
PJT
$4.41B
| $147K | ﹤0.01% |
3,610
+859
| +31% | +$35K |
|
2170
Unitil
UTL
$828M
| $147K | ﹤0.01% |
2,310
-508
| -18% | -$32.2K |
|
2171
AtriCure
ATRC
$1.73B
| $146K | ﹤0.01% |
5,868
+1,550
| +36% | +$38.7K |
|
2172
Central Pacific Financial
CPF
$813M
| $146K | ﹤0.01% |
5,153
+1,315
| +34% | +$37.3K |
|
|
AERI
2173
DELISTED
Aerie Pharmaceuticals, Inc.
AERI
| $146K | ﹤0.01% |
7,610
+2,626
| +53% | +$50.5K |
|
2174
Cars.com
CARS
$826M
| $146K | ﹤0.01% |
16,234
-1,168
| -7% | -$10.5K |
|
2175
Amneal Pharmaceuticals
AMRX
$3.08B
| $146K | ﹤0.01% |
50,240
+37,686
| +300% | +$109K |
|